Terms: = Cervical cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC
77 results:
1. The distribution of hrHPV genotypes among cervical cancer cases diagnosed across Ghana: a cross-sectional study.
Akakpo PK; Imbeah EG; Ulzen-Appiah K; Darkwa-Abrahams A; Adjei E; Amo-Antwi K; Amo EO; Der EM; Wiredu EK
BMC Infect Dis; 2024 Mar; 24(1):356. PubMed ID: 38539128
[TBL] [Abstract] [Full Text] [Related]
2. Invasive stratified mucin-producing carcinoma (ISMC) of the cervix: a clinicopathological and molecular analysis of 59 cases with special emphasis on histogenesis and potential therapeutic targets.
Yao Y; Wang Y; Ye L; Lu B; Lu W
Histopathology; 2024 Jan; 84(2):315-324. PubMed ID: 37735961
[TBL] [Abstract] [Full Text] [Related]
3. False-Positive Atypical Endocervical Cells in Conventional Pap Smears: Cyto-Histological Correlation and Analysis.
Pulkkinen J; Huhtala H; Kholová I
Acta Cytol; 2023; 67(6):604-617. PubMed ID: 37562375
[TBL] [Abstract] [Full Text] [Related]
4. 3D multifrequency magnetic resonance elastography in distinguishing endometrial and cervical adenocarcinoma.
Long L; Liu M; Deng X; Cao M; Zhang J; Lan X; Zhang J
Magn Reson Imaging; 2023 Oct; 102():62-68. PubMed ID: 37146780
[TBL] [Abstract] [Full Text] [Related]
5. Multiplex recombinase polymerase amplification for high-risk and low-risk type HPV detection, as potential local use in single tube.
Wongsamart R; Bhattarakasol P; Chaiwongkot A; Wongsawaeng D; Okada PA; Palaga T; Leelahavanichkul A; Khovidhunkit W; Dean D; Somboonna N
Sci Rep; 2023 Jan; 13(1):829. PubMed ID: 36646782
[TBL] [Abstract] [Full Text] [Related]
6. Using Silva pattern system to predict prognosis and plan treatment of invasive endocervical adenocarcinoma: a single-center retrospective analysis.
Li X; Pang S; Shen Y; Qu P
BMC Womens Health; 2022 Dec; 22(1):488. PubMed ID: 36460984
[TBL] [Abstract] [Full Text] [Related]
7. Silva cumulative score and its relationship with prognosis in Endocervical adenocarcinoma.
Li Y; Jia M; Cao L; Yu J; Gao H; Sun PL
BMC Cancer; 2022 Nov; 22(1):1172. PubMed ID: 36376880
[TBL] [Abstract] [Full Text] [Related]
8. Diagnostic utility of ThinPrep Imaging System® for detecting atypical glandular cells in cervical smear samples.
Akca Y; Erkilic S
Diagn Cytopathol; 2023 Feb; 51(2):135-139. PubMed ID: 36308412
[TBL] [Abstract] [Full Text] [Related]
9. Perspectives on the pharmacological management of esophageal cancer: where are we now and where do we need to go?
Rogers JE; Ajani JA
Expert Opin Pharmacother; 2022 Dec; 23(17):1893-1902. PubMed ID: 36286544
[TBL] [Abstract] [Full Text] [Related]
10. Endocervical Adenocarcinoma: Comprehensive Histological Review and Re-classification of 123 Consecutive Cases According to the Updated World Health Organization Classification of Female Genital Tumors.
Lee Y; Bae H; Kim HS
Anticancer Res; 2022 Sep; 42(9):4627-4639. PubMed ID: 36039458
[TBL] [Abstract] [Full Text] [Related]
11. The effect of preserving pregnancy in cervical cancer diagnosed during pregnancy: a retrospective study.
He Z; Xie C; Qi X; Hu Z; He Y
BMC Womens Health; 2022 Jul; 22(1):314. PubMed ID: 35879712
[TBL] [Abstract] [Full Text] [Related]
12. Independent validation of distinct clinicopathological features and prognosis among usual-type, mucinous-type and gastric-type endocervical adenocarcinoma categorised by new WHO classification (2020).
Shi H; Shao Y; Zhang H; Ye L; Xu E; Lu B
Pathology; 2022 Aug; 54(5):555-562. PubMed ID: 35346505
[TBL] [Abstract] [Full Text] [Related]
13. Endocervical Cytology: Inter- and Intra-Observer Variability in Conventional Pap Smears.
Pulkkinen J; Huhtala H; Krogerus LA; Hollmén S; Laurila M; Kholová I
Acta Cytol; 2022; 66(3):206-215. PubMed ID: 35226896
[TBL] [Abstract] [Full Text] [Related]
14. Hydrazonoyl chlorides possess promising antitumor properties.
El Gendy MAM; Hassanein H; Saleh FM; Karimi-Busheri F; Fanta M; Yang X; Tawfik D; Morsy S; Fahmy M; Hemid M; Abdel Azeiz M; Fared A; Weinfeld M
Life Sci; 2022 Apr; 295():120380. PubMed ID: 35143825
[TBL] [Abstract] [Full Text] [Related]
15. Endocervical neoplasia: Pathologic updates in diagnosis and prognosis.
Rivera-Colón G; Zheng W
Semin Diagn Pathol; 2022 May; 39(3):213-227. PubMed ID: 34953647
[TBL] [Abstract] [Full Text] [Related]
16. Tumoral Morphologic Features From cervical Biopsies That Are Predictive of a Negligible Risk for Nodal Metastasis and Tumor Recurrence in Usual-type cervical Adenocarcinomas: A Multi-institutional Study.
Wang Y; Chang RJ; Luo RZ; Yu J; Zhang X; Yang X; Quddus MR; Li L; Yang W; Liu A; Jiang Q; Zhao R; Zhu H; Zhou F; Wang Y; Sheng X; Liu LL; Wen YL; Banet N; Sung CJ; Qi Y; Bi R; Li M; Wang Y; Li J; Lin W; Wang Y; Rivera G; Chen H; Holloway SB; Fadare O; Liu J; Wang J; Lea J; Kong B; Zheng W
Am J Surg Pathol; 2022 May; 46(5):713-724. PubMed ID: 34753864
[TBL] [Abstract] [Full Text] [Related]
17. Grading of endocervical adenocarcinoma: a novel prognostic system based on tumor budding and cell cluster size.
Shi H; Ye L; Lu W; Lu B
Mod Pathol; 2022 Apr; 35(4):524-532. PubMed ID: 34593968
[TBL] [Abstract] [Full Text] [Related]
18. Identification of clinical trait-related small RNA biomarkers with weighted gene co-expression network analysis for personalized medicine in endocervical adenocarcinoma.
Shi Z; Qu X; Guo C; Zhang L; Peng C; Xie Z; Hua K; Qiu J
Aging (Albany NY); 2021 Sep; 13(18):22361-22374. PubMed ID: 34542422
[TBL] [Abstract] [Full Text] [Related]
19. The ISGyP Endocervical Adenocarcinoma Project: Master Plan Summary, Acknowledgment of Participants, and Participant Responses to Final Recommendations of the Expert Panels.
Singh N; Rabban JT
Int J Gynecol Pathol; 2021 Mar; 40 Suppl 1(Iss 2 Suppl 1):S111-S123. PubMed ID: 33687171
[TBL] [Abstract] [Full Text] [Related]
20. Label-Free Quantitative Comparison of cervical Mucus Peptides in Subjects With Endocervical Adenocarcinoma and Adenocarcinoma in Situ.
Shi F; Li X; Ma Z; Luan T; Zhong T; Gu Y
Technol Cancer Res Treat; 2021; 20():1533033821997825. PubMed ID: 33612089
[TBL] [Abstract] [Full Text] [Related]
[Next]
